Stay updated on Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page
- Check7 days agoChange DetectedDifference0.1%

- Check14 days agoChange DetectedThe version history shows updates to study status and recruitment/locations across multiple versions, with revised contact details for the study team. These changes reflect ongoing status updates for the trial and adjustments to access points for the site.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check28 days agoChange DetectedThe record history now includes revision v3.4.3 and removes revision v3.4.2.SummaryDifference0.1%

- Check57 days agoChange DetectedThe history now shows a new revision entry (v3.4.2) added and the previous revision (v3.4.1) removed from the log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe history shows an added revision label (v3.4.1) and removal of the previous revision (v3.4.0). This update affects only versioning metadata and does not change any study data, content, or functionality.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.